Documents & Downloads

anti-TNBC agent-2

Anticancer Compound

Anti-TNBC agent-2 is a purine derivative targeting triple-negative breast cancer (TNBC). This compound induces apoptosis in MDA-MB-231 cells, while effectively inhibiting migration and angiogenesis. Additionally, anti-TNBC agent-2 demonstrates the capability to suppress tumor growth and metastasis, as evidenced by reduced expression levels of Ki67 and CD31 proteins in TNBC xenograft models. It is a valuable tool for research focused on TNBC.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2422001-22-5
Applications	Anticancer Compound
Formula	C₂₈H₃₇ClFN₇O
Molecular Weight	542.09
SMILES	FC1=CC=C(C=C1Cl)CNC2=C3N=CN(C3=NC(N4CCC(CC4)C5CCN(CC5)CCO)=N2)CC6CC6

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.